Ask Anything
ESC 2026 DiscussionExplore the Hot Line trials, expert perspectives, and key takeawaysExplore the discussion→Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
cohort · n=3,1172 mentionsTrending on X
SEP 10BalakrishnanCirculation Heart Failure
LMNA genotype linked to ~452% higher incident AF risk vs genotype-negative DCM patients.
LMNA carriers with dilated cardiomyopathy may warrant closer AF monitoring; extends genotype-specific risk data but leaves practice change open pending trials.
cohort · n=94,516Trending on X
SEP 11LiangBMJ
New Zealand CVD risk equations calibrate poorly in Chinese diabetes cohorts but improve with age adjustments.
CVD risk equations may not generalize across high- and non-high-income settings in diabetes; leaves open need for local derivation and validation.
cohort · n=1,852Trending on X
SEP 10IzumiCirculation Heart Failure
Cardiac sarcoidosis recurrence linked to ~38% higher risk of death, HF, or fatal arrhythmias.
Recurrence identifies higher-risk patients; leaves open whether intensified monitoring or therapy improves outcomes.
cohort · n=2,1552 mentionsTrending on X
SEP 11ScottiCirculation Cardiovascular Interventions
Severe TR linked to ~101% higher 2-year all-cause mortality versus moderate or less TR.
Baseline severe TR doubles mortality risk after successful M-TEER; leaves open whether TR-directed intervention improves outcomes.
cohort · n=553
SEP 11ZaidCirculation Cardiovascular Interventions
Reintervention for failed balloon-expandable valves shows similar mortality to self-expanding valves.
Comparable reintervention mortality irrespective of initial valve type supports standardized approaches; leaves open mechanism-specific prospective trials.
RCT1 mentions
SEP 14VoorhoutNetherlands Heart Journal
DUTCH-WAIST tests whether semaglutide plus lifestyle intervention improves rhythm control in persistent AF.
DUTCH-WAIST will test semaglutide for rhythm control in overweight persistent AF; leaves open whether GLP-1 RAs improve arrhythmia outcomes pending RCT results.
RCT1 mentionsTrending on X
SEP 11GalaJournal of Interventional Cardiac Electrophysiology
Efficacy and safety of pulsed-field ablation with the pentaspline catheter versus thermal ablation in paroxysmal atrial fibrillation: a meta-analysis of randomised controlled trials
Meta-analysis of randomized trials demonstrates the efficacy and safety of pulsed-field ablation in paroxysmal atrial fibrillation, highlighting a viable non-thermal alternative.
meta-analysis · n=5,9781 mentionsTrending on X
SEP 11ZhangFrontiers in Endocrinology
Higher triglyceride-glucose index is linked to ~62% greater MACE risk per unit after CABG.
May aid post-CABG risk stratification as a metabolic marker; extends observational evidence on TyG prognostic value.
RCT
SEP 14XuCirculation
Letter by Xu et al Regarding Article, “Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial”
Correspondence analyzes early recurrence outcomes after catheter ablation for atrial fibrillation with dapagliflozin, highlighting key methodological considerations in trial interpretation.
RCT
SEP 14ZhaoCirculation
Response by Zhao et al to Letter Regarding Article, “Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for Atrial Fibrillation: The DARE-AF Randomized Clinical Trial”
Correspondence response addresses inquiries regarding dapagliflozin for recurrence after catheter ablation, highlighting methodological considerations.